Hyperliquid Strategies (NASDAQ:PURR) Price Target Raised to $9.75 at Chardan Capital

Hyperliquid Strategies (NASDAQ:PURR) had its price target hoisted by stock analysts at Chardan Capital from $8.45 to $9.75 in a report released on Wednesday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Chardan Capital’s price objective suggests a potential upside of 25.16% from the company’s previous close.

PURR has been the topic of a number of other research reports. Wall Street Zen upgraded shares of Hyperliquid Strategies to a “hold” rating in a research note on Saturday, February 21st. Maxim Group assumed coverage on shares of Hyperliquid Strategies in a research note on Friday, April 24th. They set a “buy” rating and a $10.00 price target on the stock. Weiss Ratings assumed coverage on shares of Hyperliquid Strategies in a research note on Monday, March 2nd. They set a “sell (e)” rating on the stock. Finally, Cantor Fitzgerald lifted their price target on shares of Hyperliquid Strategies from $6.00 to $8.00 and gave the stock an “overweight” rating in a research note on Monday, May 11th. Three equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $9.25.

Hyperliquid Strategies Price Performance

PURR opened at $7.79 on Wednesday. Hyperliquid Strategies has a fifty-two week low of $3.01 and a fifty-two week high of $7.94. The business’s fifty day simple moving average is $5.90. The firm has a market capitalization of $1.05 billion, a P/E ratio of -1.06 and a beta of 1.44.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Boothbay Fund Management LLC bought a new position in shares of Hyperliquid Strategies during the fourth quarter valued at $40,000. Bank of America Corp DE lifted its holdings in shares of Hyperliquid Strategies by 896.4% during the first quarter. Bank of America Corp DE now owns 238,080 shares of the company’s stock valued at $1,212,000 after acquiring an additional 214,187 shares during the period. Bank of New York Mellon Corp bought a new position in shares of Hyperliquid Strategies during the first quarter valued at $142,000. Bank of Nova Scotia bought a new position in shares of Hyperliquid Strategies during the first quarter valued at $204,000. Finally, OLP CAPITAL MANAGEMENT Ltd bought a new position in shares of Hyperliquid Strategies during the first quarter valued at $10,459,000. 9.45% of the stock is owned by institutional investors.

Hyperliquid Strategies Company Profile

Hyperliquid Strategies Inc is a digital asset treasury company whose primary focus is to maximize shareholder value through accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. Hyperliquid Strategies Inc, formerly known as Sonnet BioTherapeutics Holdings Inc, is based in NEW YORK.